Dynamics of a heparin-binding domain of VEGF165 complexed with its inhibitor triamterene

Biochemistry

Volumn 50, Issue 22, 2011, Pages 4843-4854

  Jeong, Ki Woong ^a   Lee, Jee Young ^a   Lee, Sung Ah ^a   Yang, Seung Pil ^b   Ko, Hyunsook ^a   Kang, Dong Il ^a   Chae, Chi Bom ^b   Kim, Yangmee ^a  

^a Konkuk University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER'S DISEASE; AMIDE PROTON; ANGIOGENESIS; AROMATIC RINGS; BACKBONE DYNAMICS; BINDING MODELS; BIOLOGICAL ACTIVITIES; C-TERMINUS; CONFORMATIONAL EXCHANGE; DYNAMIC FEATURES; DYNAMIC PROPERTY; HEPARIN BINDING; HYDROPHOBIC INTERACTIONS; LOOP REGIONS; MODEL-FREE ANALYSIS; NEUROPROTECTIVE EFFECTS; NEUROTROPHIC; PHENYL RINGS; SENILE PLAQUES; SPIN-RELAXATION RATES; STRUCTURAL FLEXIBILITIES; TRIAMTERENE; VASCULAR ENDOTHELIAL GROWTH FACTOR;

AMIDES; AMINO ACIDS; BINDING SITES; BIOACTIVITY; CONFORMATIONS; FEATURE EXTRACTION; HYDROGEN BONDS; HYDROPHOBICITY; INVESTMENTS; SPIN DYNAMICS;

POLYSACCHARIDES;

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; HEPARIN; PTERIDINE; REACTIVE OXYGEN METABOLITE; TRIAMTERENE; VASCULOTROPIN 165; VASCULOTROPIN RECEPTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BETA SHEET; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; DRUG PROTEIN BINDING; HEPARIN BINDING DOMAIN; HYDROGEN BOND; MOLECULAR DOCKING; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RAT;

BINDING SITES; HEPARIN; HUMANS; HYDROGEN BONDING; MODELS, MOLECULAR; PROTEIN CONFORMATION; TRIAMTERENE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79958045498     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi2000752     Document Type: Article

References (72)

1. Yankner, B. A. (1996) Mechanisms of neuronal degeneration in Alzheimer's disease Neuron 16, 921-932 (Pubitemid 26171198)
2. Hardy, J. and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297, 353-356 (Pubitemid 34790756)
3. Sommer, B. (2002) Alzheimer's disease and the amyloid cascade hypothesis: 10 years on Curr. Opin. Pharmacol. 2, 87-92
4. Yang, S.-P., Bae, D.-G., Kang, H. J., Gwag, B. J., Gho, Y. S., and Chae, C.-B. (2004) Co-accumulation of vascular endothelial growth factor with β-amyloid in the brain of patients with Alzheimer's disease Neurobiol. Aging 25, 283-290 (Pubitemid 38220962)
5. Yang, S.-P., Kwon, B. O., Cho, Y. S., and Chae, C.-B. (2005) Specific interaction of VEGF165 with β-amyloid, and its protective effect on β-amyloid-induced neurotoxicity J. Neurochem. 93, 118-127 (Pubitemid 40463521)
6. Dvorak, H. F., Brown, L. F., Detmar, M., and Dvorak, A. M. (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis Am. J. Pathol. 146, 1029-1039
7. Ferrara, N. (1995) The role of vascular endothelial growth factor in pathological angiogenesis Breast Cancer Res. Treat. 36, 127-137
8. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W., and Nagy, A. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele Nature 380, 435-439 (Pubitemid 26102719)
9. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., and Moore, M. W. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene Nature 380, 439-442 (Pubitemid 26102720)
10. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease Nature Med. 1, 27-31
11. Jin, K. L., Mao, X. O., and Greenberg, D. A. (2000) Vascular endothelial growth factor rescues HN33 neural cells from death induced by serum withdrawal J. Mol. Neurosci. 14, 197-203 (Pubitemid 30660810)
12. Jin, K. L., Mao, X. O., and Greenberg, D. A. (2000) Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia Proc. Natl. Acad. Sci. U.S.A. 97, 10242-10247
13. Storkebaum, E. and Carmeliet, P. (2004) VEGF: a critical player in neurogeneration J. Cin. Invest. 113, 14-18
14. Muller, Y. A., Christinger, H. W., Keyt, B. A., and de Vos, A. M. (1997) The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 Å resolution: multiple copy flexibility and receptor binding Structure 5, 1325-1338 (Pubitemid 27484475)
15. Sun, P. D. and Davies, D. R. (1995) The cystine-knot growth-factor superfamily Annu. Rev. Biophys. Biomol. Struct. 24, 269-291
16. McDonald, N. Q. and Hendrickson, W. A. (1993) A structural superfamily of growth factors containing a cystine knot motif Cell 73, 421-424 (Pubitemid 23143340)
17. Murray-Rust, J., McDonald, N. Q., Blundell, T. L., Hosang, M., Oefner, C., Winkler, F., and Bradshaw, R. A. (1993) Topological similarities in TGF-β2, PDGF-BB and NGF define a superfamily of polypeptide growth factors Structure 1, 153-159
18. Isaacs, N. W. (1995) Cystine knots Curr. Opin. Struct. Biol. 5, 391-395
19. Ferrara, N. (2009) Vascular endothelial growth factor: Basic biology and clinical applications Curr. Clin. Onco. 1, 11-21
20. Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., and De Bruijn, E. A. (2004) Vascular endothelial growth factor and angiogenesis Pharmacol. Rev. 56, 549-580 (Pubitemid 39658463)
21. Keyt, B. A., Berleau, L. T., Nguyen, H. V., Chen, H., Heinsohn, H., Vandlen, R., and Ferrara, N. (1996) The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency J. Biol. Chem. 271, 7788-7795 (Pubitemid 26111064)
22. Krilleke, D., Ng, Y. S., and Shima, D. T. (2009) The heparin-binding domain confers diverse functions of VEGF-A in development and disease: a structure-function study Biochem. Soc. Trans. 37, 1201-1206
23. Ashikari-Hada, S., Habuchi, H., Kariya, Y., and Kimata, K. (2005) Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. Comparison of the effects of heparin and modified heparins J. Biol. Chem. 280, 31508-31515 (Pubitemid 41291893)
24. 165•KDR complexes J. Biol. Chem. 276, 39748-39754
25. Fairbrother, W. J., Champe, M. A., Christinger, H. W., Keyt, B. A., and Starovasnik, M. A. (1998) Solution structure of the heparin-binding domain of vascular endothelial growth factor Structure 15, 637-648 (Pubitemid 28258116)
26. Stauffer, M. E., Skelton, N. J., and Fairbrother, W. J. (2002) Refinement of the solution structure of the heparin binding domain of vascular endothelial growth using residual dipolar coupling J. Biomol. NMR 23, 57-61 (Pubitemid 34546146)
27. Chae, C. B., Gho, Y. S., Yang, S., Bae, D. G., Kwon, B. O., and Hwang, S. (2010) Methods of Contacting β amyloid protein with VEGF, U.S. Patent 7,795,213 B2.
28. Mukne, A. P. and Nagarsenker, M. S. (2004) Triamterene-β- cyclodextrin systems: preparation, characterization and in vivo evaluation AAPS Pharm. Sci. Tech. 5, 142-150
29. Eisenmesser, E. Z., Bosco, D. A., Akke, M., and Kern, D. (2002) Enzyme dynamics during catalysis Science 295, 1520-1523 (Pubitemid 34174006)
30. Venkitakrishnan, R. P., Zaborowski, E., McElheny, D., Benkovic, S. J., Dyson, H. J., and Wright, P. E. (2004) Conformational changes in the active site loops of dihydrofolate reductase during the catalytic cycle Biochemistry 43, 16046-16055 (Pubitemid 40041018)
31. Cole, R. and Loria, J. P. (2002) Evidence for flexibility in the function of ribonuclease A Biochemistry 41, 6072-6081 (Pubitemid 34498913)
32. Codreanu, S. G., Ladner, J. E., Xiao, G. Y., Stourman, N. V., Hachey, D. L., Gilliland, G. L., and Armstrong, R. N. (2002) Local protein dynamics and catalysis: Detection of segmental motion associated with rate-limiting product release by a glutathione transferase Biochemistry 41, 15161-15172 (Pubitemid 36008124)
33. Bae, D.-G., Gho, Y.-S., Yoon, W.-H., and Chae, C.-B. (2000) Arginine-rich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis J. Biol. Chem. 275, 13588-13596 (Pubitemid 30257426)
34. Bae, D.-G., Kim, T. D., Li, G., Yoon, W.-H., and Chae, C.-B. (2005) Anti-Flt1 peptide, a vascular endothelial growth factor receptor 1- Specific hexapeptide, inhibits tumor growth and metastasis Clin. Cancer Res. 11, 2651-2661 (Pubitemid 40569466)
35. Levine, H., III (1993) Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution Protein Sci. 2 (3) 404-410
36. Goodsell, D. S., Morris, G. M., and Olson, A. J. (1996) Automated docking of flexible ligands: applications of AutoDock J. Mol. Recognit. 9 (1) 1-5 (Pubitemid 126565462)
37. Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., and Olson, A. J. (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function J. Comput. Chem. 19, 1639-1662 (Pubitemid 128590223)
38. Marion, E., Driscoll, P. C., Kay, L. E., Wingfield, P. T., Bax, A., Gronenborn, A. M., and Clore, G. M. (1989) Overcoming the overlap problem in the assignment of 1H NMR spectra of larger proteins by use of three dimensional heteronuclear 1H-15N Hartmann-Hahn-multiple quantum coherence and nuclear overhauser-multiple quantum coherence spectroscopy: application to interleukin 1 beta Biochemistry 28, 6150-6156 (Pubitemid 19202002)
39. Cavanagh, J. and Rance, M. (1990) Sensitivity improvement in isotropic mixing (TOCSY) experiments J. Magn. Reson. 88, 72-85
40. Kordel, J., Skelton, N. J., Akke, M., Plamer, A. G., III, and Chazin, W. J. (1992) Backbone dynamics of calcium-loaded calbindin D9k studied by two dimensional proton-detected 15N NMR spectroscopy Biochemistry 31, 4856-4866
41. Skelton, N. J., Palmer, A. G., III, Akke, M., Kördel, J., Rance, M., and Chazin, W. J. (1993) Practical aspects of two-dimensional proton-detected 15N spin relaxation measurements J. Magn. Reson., Ser. B 102, 253-264
42. Kay, L. E., Keifer, P., and Saarinen, T. (1992) Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity J. Am. Chem. Soc. 114, 10663-10665
43. Kempf, J. G. and Loria, J. P. (2003) in Protein NMR Techniques (Downing, A. K., Ed.) Humana Press, Totowa.
44. Delaglio, F., Grzesiak, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes J. Biomol. NMR 6, 277-293
45. Goddard, T. D. and Kneller, D. G. SPARKY 3, University of California, San Francisco.
46. Lipari, G. and Szabo, A. (1982) Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity J. Am. Chem. Soc. 104, 4546-4559
47. Lipari, G. and Szabo, A. (1982) Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 2. Analysis of experimental results J. Am. Chem. Soc. 104, 4559-4570
48. Cole, R. and Loria, J. P. (2003) Fast-modelfree: a program for rapid automated analysis of solution NMR spin-relaxation data J. Biomol. NMR 26, 203-213 (Pubitemid 36758441)
49. Clore, G. M., Szabo, A., Bax, A., Kay, L. E., Driscoll, P. C., and Gronenborn, A. M. (1990) Deviations from the simple two-parameter model-free approach to the interpretation of 15N nuclear magnetic relaxation of proteins J. Am. Chem. Soc. 112, 4989-4991 (Pubitemid 20285925)
50. Palmer, A. G., III, Rance, M., and Wright, P. E. (1991) Intramolecular motions of a zinc finger DNA-binding domain from Xfin characterized by proton detected natural abundance 13C heteronuclear NMR spectroscopy J. Am. Chem. Soc. 113, 4371-4380
51. Mandel, A. M., Akke, M., and Palmer, A. G., III (1995) Backbone dynamics of Escherichia coli ribonuclease HI: correlations with structure and function in an active enzyme J. Mol. Biol. 246, 144-163
52. Tjandra, N., Feller, S. E., Pastor, R. W., and Bax, A. (1995) Rotational diffusion anisotropy of human ubiquitin from 15N NMR relaxation J. Am. Chem. Soc. 117, 12562-12566
53. Hiyama, Y., Niu, C.-H., Silverton, J. V., Bavoso, A., and Torchia, D. A. (1988) Determination of 15N chemical shift tensor via 15N-2H dipolar coupling in Boc-glycylglycyl [15N glycine] benzyl ester J. Am. Chem. Soc. 110, 2378-2383
54. Fairbrother, W. J., Liu, J., Pisacane, P. I., Sliwkowski, M. X., and Palmer, A. G., III (1998) Backbone dynamics of the EGF-like domain of heregulinalpha J. Mol. Biol. 279, 1149-1161 (Pubitemid 28302391)
55. Lamy, S., Gingras, D., and Beliveau, R. (2002) Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation Cancer Res. 62, 381-385 (Pubitemid 34106408)
56. Kondo, T., Ohta, T., Igura, K., Hara, Y., and Kaji, K. (2002) Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding Cancer Lett. 180, 139-144 (Pubitemid 34327366)
57. Pellecchia, M., Sebbel, P., Hermanns, U., Wuthrich, K., and Glockshuber, R. (1999) Pilus chaperone FimC-adhesin FimH interactions mapped by TROSY-NMR Nat. Struct. Biol. 6, 336-339 (Pubitemid 29166481)
58. Muller, Y. A., Li, B., Christinger, H. W., Wells, J. A., Cunningham, B. C., and de Vos, A. M. (1997) Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site Proc. Natl. Acad. Sci. U.S.A. 94, 7192-7197 (Pubitemid 27345291)
59. Starovasnik, M. A., Christinger, H. W., Wiesmann, C., Champe, M. A., de Vos, A. M., and Skelton, N. J. (1999) Solution structure of the VEGF-binding domain of Flt-1: comparison of its free and bound states J. Mol. Biol. 293, 531-544 (Pubitemid 29512054)
60. Iyer, S., Darley, P. I., and Acharya, K. R. (2010) Structural insights into the binding of vascular endothelial growth factor-B by VEGFR-1(D2): recognition and specificity J. Biol. Chem. 285, 23779-23789
61. Muller, Y. A., Chen, Y., Christinger, H. W., Li, B., Cunningham, B. C., Lowman, H. B., and de Vos, A. M. (1998) VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface Structure 6, 1153-1167 (Pubitemid 28434118)
62. Wiesmann, C., Christinger, H. W., Cochran, A. G., Cunningham, B. C., Fairbrother, W. J., Keenan, C. J., Meng, G., and de Vos, A. M. (1998) Crystal structure of the complex between VEGF and a receptor-blocking peptide Biochemistry 37, 17765-17772 (Pubitemid 29023931)
63. Chen, Y., Wiesmann, C., Fuh, G., Li, B., Christinger, H. W., McKay, P., de Vos, A. M., and Lowman, H. B. (1999) Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen J. Mol. Biol. 293, 865-881 (Pubitemid 29527672)
64. Appleton, B. A., Wu, P., Maloney, J., Yin, J., Liang, W. C., Stawicki, S., Mortara, K., Bowman, K. K., Elliott, J. M., Desmarais, W., Bazan, J. F., Bagri, A., Tessier-Lavigne, M., Koch, A. W., Wu, Y., Watts, R. J., and Wiesmann, C. (2007) Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding EMBO J. 26, 4902-4912 (Pubitemid 350191304)
65. Leonard, P., Scotney, P. D., Jabeen, T., Iyer, S., Fabri, L. J., Nash, A. D., and Acharya, K. R. (2008) Crystal structure of vascular endothelial growth factor-B in complex with a neutralising antibody Fab fragment J. Mol. Biol. 384, 1203-1217
66. Krilleke, D., DeErkenez, A., Schubert, W., Giri, I., Robinson, G. S., Ng, Y. S., and Shima, D. T. (2007) Molecular mapping and functional characterization of the VEGF164 heparin-binding domain J. Biol. Chem. 282, 28045-28056 (Pubitemid 47533565)
67. Long, D. and Yang, D. (2010) Millisecond timescale dynamics of human liver fatty acid binding protein: testing of its relevance to the ligand entry process Biopys. J. 98 (12) 3054-53061
68. Baldwin, A. J. and Kay, L. E. (2009) NMR spectroscopy brings invisible protein states into focus Nat. Chem. Biol. 5 (11) 808-814
69. Loria, J. P., Berlow, R. B., and Watt, E. D. (2008) Characterization of enzyme motions by solution NMR relaxation dispersion Acc. Chem. Res. 41 (2) 214-221
70. Grey, M. J., Wang, C., and Palmer, A. G., III (2003) Disulfide bond isomerization in basic pancreatic trypsin inhibitor: Multisite chemical exchange quantified by CPMG relaxation dispersion and chemical shift modeling J. Am. Chem. Soc. 125, 14324-14335 (Pubitemid 37452371)
71. 15N NMR relaxation studies of free and ligand-bound human acidic fibroblast growth factor J. Biol. Chem. 275, 39444-39450 (Pubitemid 32058969)
72. Koradi, R., Billeter, M., and Wuthrich, K. (1996) MOLMOL: a program for display and analysis of macromolecular structures J. Mol. Graphics 14, 51-55 (Pubitemid 26152976)